Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe.

Abstract

UNLABELLED:

From September 1989 until September 1993, stool specimens and sera from 113 children with diarrhoea-associated haemolytic uraemic syndrome (HUS) from the Netherlands, two university hospitals in Belgium and one university hospital in Germany were examined for the presence of verocytotoxin-producing Escherichia coli (VTEC) infection. Evidence for VTEC infection was observed in 88 (78%) patients with HUS compared to 2 (3%) of the 65 children with acute gastro-enteritis Serotype O157 was the causative agent in 76 (86%) of these 88 patients with VTEC-associated HUS and verocytotoxin-2 (VT-2) was the most frequent toxin produced. Serological testing for antibodies to O157 O-antigen yielded the highest number of positive results compared to the other test methods. Antibodies to O157 were found in sera of 71 (65%) of 110 patients with HUS and one control serum. Stool and sera examination for VTEC in 95 family contacts of 28 patients with HUS demonstrated an evidence for VTEC infection 33 (35%). In contrast, in patients with HUS serological antibodies to O157 O-antigen were found in only 3 (4%) of 85 family contacts.

CONCLUSION:

In this part of Western Europe, VT2-producing Escherichia coli, mainly those belonging to serogroup O157, are the major cause of HUS in childhood.

• Authors: N C van de Kar, H G Roelofs, H L Muytjens, J J Tolboom, B Roth, W Proesmans, W C Reitsma-Bierens, E D Wolff, M A Karmali, H Chart, L A Monnens
• Journal: European journal of pediatrics (Eur J Pediatr) Vol. 155 Issue 7 Pg. 592-5 (Jul 1996) ISSN: 0340-6199 [Print] Germany
• PMID: 8831084 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)

Chemical References

• Bacterial Toxins

Topics

• Bacterial Toxins (classification)
• Belgium (epidemiology)
• Case-Control Studies
• Child
• Child, Preschool
• Escherichia coli Infections (complications, microbiology)
• Female
• Gastroenteritis (complications, microbiology)
• Germany (epidemiology)
• Hemolytic-Uremic Syndrome (epidemiology)
• Humans
• Infant
• Male
• Netherlands (epidemiology)
• Prospective Studies
• Serotyping